Publications

Since 2001, the Pediatric Heart Network has published and presented over 150 manuscripts, 85 abstracts, and 75 posters/presentations. This is a complete listing of all manuscripts, categorized by study.

description

About PHN

(PHN Landmark Publications)

These articles describe the structure and tasks of the PHN, review existing studies, and describe challenges and opportunities for pediatric research in congenital heart defects and acquired heart disease.

  • Clinical Research Careers: Reports from a NHLBI Pediatric Heart Network Clinical Research Skills Development Conference

    W. Lai, Am Heart J 2011; 161:13-67.

    Read Publication

  • Report of the Pediatric Heart Network and National Heart, Lung, and Blood Institute Working Group on the perioperative management of congenital heart disease

    J. Kaltman, Circulation 2010; 121:2766-72.

    Read Publication

  • The Pediatric Heart Network: A Primer for the Conduct of Multicenter Studies in Children with Congenital and Acquired Heart Disease

    L. Mahony, Pediatr Cardiol 2006; 27:191-198.

    Read Publication

description

Collaborative Learning

(Observational Study)

The Collaborative Learning study compared how well babies did after surgery at heart centers where babies were removed from the ventilator early versus at sites where babies were not taken off the ventilators early.

  • Utilizing a Collaborative Learning Model to Promote Early Extubation Following Infant Heart Surgery

    W. T. Mahle, Pediatr Crit Care Med; 2016 Oct;17(10):939-947.

    This study compared how well babies did after surgery, for Tetralogy of Fallot or coarctation of the aorta, at research sites where babies were removed from the ventilator early (called early extubation) versus at research sites where babies were not taken off the ventilators early. The clinical practice guideline used at the intervention sites significantly increased the rate of early extubation with no change in the rate of reintubation or postoperative ICU length of stay.

    Read Publication

  • Rationale and Methodology of a Collaborative Learning Project in Congenital Cardiac Care

    M. J. Wolf, Am Heart J; 2016 Apr;174:129-37.

    This paper describes how collaborative learning was used to develop a clinical practice guideline to design a study examining early extubation of babies after heart surgery.

    Read Publication

  • Hospital Costs Related to Early Extubation After Infant Cardiac Surgery

    K. E. McHugh, Ann Thorac Surg. 2019 May;107(5):1421-1426.

    Read Publication

description

Dexmedetomidine

(Dosing Study)

The purpose of this study was to figure out safe doses of a medicine called dexmedetomidine for babies having heart surgery.

  • Results of a phase 1 multicentre investigation of dexmedetomidine bolus and infusion in corrective infant cardiac surgery

    A. F. Zuppa, Br J Anaesth. 2019 Dec;123(6):839-852.

    Read Publication

description

Echo Z-Score & Normal Electrocardiogram

(Observational Study)

The objectives of this study were to establish a Z-score database for common echo measurements based on a uniformly defined and racially diverse population of normal children from multiple centers over a wide geographic area and to collect electrocardiograms (ECG) from the same population for future establishment of ECG reference values.

  • Relationship of Echocardiographic Z Scores Adjusted for Body Surface Area to Age, Sex, Race, and Ethnicity: The Pediatric Heart Network Normal Echocardiogram Database

    L. Lopez, Circ Cardiovasc Imaging 2017; 10(11):e006979.

    Data were collected on 3566 healthy nonobese children ≤18 years of age with normal echocardiograms to produce reference values for echocardiogram measurements based on age, sex, race, ethnicity, height and weight. Body size was found to be the best predictor of the sizes of cardiovascular structures, and age, sex, and race did not have a clinically significant effect on this relationship.

    Read Publication

  • Electrocardiograms in Healthy North American Children in the Digital Age

    E.V. Saarel, Circ Arrhythm Electrophysiol 2018 Jul;11(7):e005808.

    Electrocardiography is a cornerstone in the cardiac evaluation of children. Wide variation in previously published data, much of which was obtained before the digital era, provided a strong motivation to obtain more reliable data on electrocardiogram (ECG) measurements in healthy children from North America. This study found that most ECG measurements varied by sex and race and differed from prior studies done in smaller, more racially and ethnically homogeneous populations. This study provides valuable data that can be used clinically for interpreting pediatric ECGs in the modern era for diagnosis or screening of heart disease in North America, particularly for Long QT syndrome and left ventricular hypertrophy.

    Read Publication

  • Challenges With Left Ventricular Functional Parameters: The Pediatric Heart Network Normal Echocardiogram Database

    P. C. Frommelt, J Am Soc Echocardiogr. 2019 Oct;32(10):1331-1338.e1.

    Read Publication

  • Challenges and lessons learned from the Pediatric Heart Network Normal Echocardiogram Database study

    D. Truong, Cardiol Young. 2020 Apr;30(4):456-461.

    Read Publication

description

Fontan

(Observational Study)

This study was done to survey the health status of patients after Fontan surgery and to better understand how tests performed routinely to evaluate heart function relate to overall health status in patients after Fontan surgery.

  • Contemporary Outcomes After the Fontan Procedure: A Pediatric Heart Network Multicenter Study

    P. Anderson, J Am Coll Cardiol 2008; 52:85-98.

    The Fontan study was designed to study children born with a single ventricle or heart pumping chamber who underwent a type of surgery called the Fontan procedure Data was collected from 546 children between 6 and 18 years of age about their heart structure and function after surgery, ability to exercise, heart rhythm and certain lab tests. Questions were asked to assess physical, mental, and emotional well being. The study showed that most Fontan survivors had a normal sense of well being. Most had normal ability for the heart to squeeze, but the majority had decreased relaxation of the heart muscle. Ability to exercise was also decreased in most. Children with a single right ventricle (pumping chamber) had decreased function of the heart and its valves compared with children with a single left ventricle. If the Fontan procedure was done at an older age, heart valves did not work as well and children were less likely to have a normal heart rhythm.

    Read Publication

  • Design of a Large Cross-Sectional Study to Facilitate Future Clinical Trials in Children with the Fontan Palliation

    L. Sleeper, Am Heart J 2006; 152:427-433.

    This article describes how the Fontan study was designed and implemented in the Pediatric Heart Network. The purpose of the study was to determine whether clinical measures of how well the heart is working (such as lab tests, exercise testing, and echocardiogram) compare with health status (quality of life) in patients who have had a Fontan procedure for congenital heart disease. The data will help researchers design future clinical trial.

    Read Publication

  • Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms

    A. Ostrow, Ann Thorac Surg 2006; 82:695-700.

    Read Publication

  • Impaired Power Output and Cardiac Index with Hypoplastic Left Heart Syndrome: A Magnetic Resonance Imaging Study

    K. Sundareswaran, Ann Thorac Surg 2006; 82(4):1267-75; discussion 1275-77.

    Read Publication

  • Flow Study of an Extra-Cardiac Connection with Persistent Left Superior Vena Cava

    D. de Zélicourt, J Thorac Cardiovasc Surg 2006; 131:785-91.

    Read Publication

  • Relationship of Patient and Medical Characteristics to Health Status in Children and Adolescents after the Fontan Procedure

    B. McCrindle, Circulation 2006; 113:1123-1129.

    Children with a single ventricle (heart pumping chamber) who have undergone the Fontan procedure are at risk of having poor health because of frequent hospitalizations and surgeries, decreased ability to exercise, and other medical problems. Parents of children in the Fontan study answered questions about their child’s physical activity, behavior, emotions and self-esteem. The results showed that as a group, children who have had the Fontan procedure have more problems with vision, speech, hearing, attention, learning, behavior, anxiety and depression compared to children in the general population. The impact of these other problems was made worse by having a lower family income. Future research is needed to identify ways to diagnose, prevent and treat these problems and to recognize the impact they have on children who have had the Fontan procedure.

    Read Publication

  • Physical Activity Levels in Children and Adolescents are Reduced After the Fontan Procedure, Independent of Exercise Capacity, and are Associated with Lower Perceived General Health

    B. McCrindle, Arch Dis Child 2007; 92:509-514.

    The Pediatric Heart Network studied 147 of the children in the Fontan study to see how physically active they were on a daily basis. The researchers found that these children participated in physical activity far less often than healthy children, even if their exercise tests showed that they are able to exercise. Children who spent less time being physically active believed they were less healthy overall, whereas children who were not able to exercise as well not only believed they were less healthy, but also had lower level of physical function and self-esteem.

    Read Publication

  • Functional State of Patients with Heterotaxy Syndrome Following the Fontan Operation

    A. Atz, Cardiol Young 2007; 17 Suppl 2:44-53.

    Children with heterotaxy syndrome have been found to have poorer outcomes compared to children with other complex heart problems, even if those children undergo the same surgeries. Eight percent of children in the Fontan study were found to have heterotaxy syndrome. Those children with heterotaxy were compared to children in the Fontan study without heterotaxy, in regards to their medical and surgical history, heart structure and function, ability to exercise, and health status. The study showed that there were no real differences between the two groups in the children’s sense of physical and psychosocial well-being or ability to exercise.

    Read Publication

  • The Fontan Procedure Our Odyssey Continues

    C. Backer, J Am Coll Cardiol 2008; 52:114-116.

    This article describes the results of the Fontan study and how those results may change the way we care for children who will need to have the Fontan procedure.

    Read Publication

  • A Cross-Sectional Study of Exercise Performance During the First 2 Decades of Life After the Fontan Operation

    S. Paridon, J Am Coll Cardiol 2008; 52:99-107.

    This study discusses the exercise performance of a large group of children in the Fontan study. Of the 546 children in the study, 411 had exercise testing performed, and most (60%) were not able to exercise to peak levels. Those who were able to reach peak exercise were more likely to be older. Many reported fatigue as a reason for not reaching peak exercise. The wide range of performance was found to be related to the whether the heart is able to increase the amount of blood squeezed out of the pumping chamber (stroke volume). The study also showed that as males go through puberty and gain more muscle, the heart after a Fontan procedure may not be able to keep up with increased demands, making exercise more difficult.

    Read Publication

  • Functional Status, Heart Rate, and Rhythm Abnormalities in 521 Fontan Patients 6-18 Years of Age

    A. Blaufox, J Thorac Cardiovasc Surg 2008; 136:100-107.

    Problems with heart rate and rhythm are common after the Fontan procedure. The purpose of this study was to see if daily health status in children enrolled in the Fontan study was affected by heart rate or rhythm disorders. Researchers found that a lower resting heart rate and a higher heart rate during exercise were only weakly associated with better physical health. Therefore, other factors may have more impact on how children function after then Fontan procedure.

    Read Publication

  • Functional State Following the Fontan Procedure

    I. Williams, Cardiol Young 2009; 15:1-11.

    Despite improvements in outcomes after surgery, the functional state varies in children who have had the Fontan procedure. This study developed a scoring system for overall function, looking at how the pumping chamber squeezes, the ability to exercise, physical well-being, and certain lab tests. Lower overall function after surgery was found in children who have a right heart pumping chamber, heart pressures that are higher than normal, lower oxygen levels before surgery, abnormal heart rhythms after surgery, and lower income of their caregiver.

    Read Publication

  • Comparison of Echocardiographic and Cardiac Magnetic Resonance Imaging Measurements of Functional Single Ventricular Volumes, Mass, and Ejection Fraction (From the Pediatric Heart Network Multicenter Fontan Cross-Sectional Study)

    R. Margossian, Am J Cardiol 2009; 104:419-428.

    The size and function of a single heart pumping chamber (ventricle) are key elements when managing patients after the Fontan procedure. Children in the Fontan study had echocardiograms and MRIs performed as part of the study. This article describes how closely the measurements compare between different doctors who read the studies.

    Read Publication

  • Parent Versus Child-Reported Functional Health Status After the Fontan Procedure

    L. Lambert, Pediatrics 2009; 124:e942-949.

    Children ages 10-18 enrolled in the Fontan study and their parents completed forms to assess the child’s health status. Parents’ perceptions of the functional health status of their children after the Fontan procedure were worse than the children’s perceptions of their own well being in several areas.

    Read Publication

  • Blood Flow Distribution in a Large Series of Fontan Patients: A Cardiac Magnetic Resonance Velocity Mapping Study

    K. K. Whitehead, J Thorac Cardiovasc Surg. 2009 Jul; 138(1): 96–102.

    Read Publication

  • Laboratory Measures of Exercise Capacity and Ventricular Characteristics and Function are Weakly Associated with Functional Health Status After Fontan Procedure

    B. McCrindle, Circulation 2010; 121:34-42.

    This study looked at how the well being of children who were in the Fontan study related to the test results from echocardiography, MRI, blood and exercise tests. The results showed that the results of these tests were only weakly associated with health status. This suggests that these tests may not be good markers for functional health status.

    Read Publication

  • Anthropometric measures after the Fontan procedure: Implications for suboptimal functional outcome

    M. Cohen, Am Heart J 2010; 160:1092-1098.e1.

    Read Publication

  • The Fontan patient: inconsistencies in medication therapy across seven pediatric heart network centers

    P. Anderson, Pediatr Cardiol 2010; 31(8): 1219–1228.

    Read Publication

  • Relation of the size of secondary ventricles to exercise performance in children after a Fontan operation

    A. Prakash, Am J Cardiol 2010; 106(11):1652-6.

    Read Publication

  • Arrhythmias in a contemporary Fontan cohort: prevalence and clinical associations in a multi-center cross-sectional study

    E. Stephenson, J Am Coll Cardiol 2010; 56:890-6.

    Read Publication

  • Living at an altitude adversely affects exercise capacity in Fontan patients

    J. R. Darst, Cardiol Young. 2010 Dec; 20(6): 593–601.

    Read Publication

  • Non-Geometric Echocardiographic Indices of Ventricular Function in Patients with a Fontan Circulation

    J. Rhodes, J Am Soc Echocardiogr 2011; 24:1213-9.

    Read Publication

  • Practice variability and outcomes of coil embolization of aortopulmonary collaterals before Fontan completion: A report from the Pediatric Heart Network Fontan Cross-Sectional Study

    P. Banka, Am Heart J 2011; 162:125-130.

    Read Publication

  • Late Status of Fontan patients with Persistent Surgical Fenestration

    A. Atz, J Am Coll Cardiol 2011; 57:2437-43.

    Read Publication

  • Factors associated with serum brain natriuretic peptide levels after the Fontan procedure

    A. Atz, Congenit Heart Dis 2011; 6:313-321.

    Read Publication

  • Factors Impacting Echocardiographic Imaging after the Fontan Procedure: A Report from the Pediatric Heart Network Fontan Cross-Sectional Study

    R. Williams, Echocardiography 2013; 30:1098-1106.

    Read Publication

  • Cardiac performance and quality of life in patients who have undergone the Fontan procedure with and without prior superior cavopulmonary connection

    A. Atz, Cardiol Young 2013; 23(3): 335–343.

    Read Publication

  • Comparison of Fontan Survivors with and without Pacemakers: A Report from the Pediatric Heart Network Fontan Cross-sectional Study

    R. Williams, Congenit Heart Dis 2013;8(1): 32–39.

    Read Publication

  • Age at Fontan procedure impacts exercise performance in adolescents: results from the Pediatric Heart Network Multicenter study

    P. Madan, Am Heart J. 2013 Aug;166(2):365-372.e1.

    Read Publication

  • Functional health status in children and adolescents after Fontan: Comparison of generic and disease-specific assessment

    B. McCrindle, Cardiol Young 2014; 24(3): 469–477.

    Read Publication

  • Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity

    A. R. Opotowsky, Am J Physiol Heart Circ Physiol. 2014 Jul 1;307(1):H110-7.

    Read Publication

  • Assessment of Diastolic Function in Single-Ventricle Patients After the Fontan Procedure

    R. Margossian, J Am Soc Echocardiogr 2016 Nov;29(11):1066-1073.

    Read Publication

  • Impact of Cardiac Rehabilitation on the Exercise Function of Children with Serious Congenital Heart Disease

    J. Rhodes, Pediatrics 2005; 116(6):1339-1345.

    Children with congenital heart disease (CHD) often can’t exercise as well as their peers. Part of this may be due to their heart defect and part may be that they may not be very physically active. A 12-week cardiac rehabilitation program was designed to see if children could improve their ability to exercise safely. Sixteen patients completed the program. Improvements were found in 15 of 16 patients and no patient had any heart problems from the exercise.

    Read Publication

  • Sustained Effects of Cardiac Rehabilitation in Children with Serious Congenital Heart Disease

    J. Rhodes, Pediatrics 2006; 118(3):e586-593.

    Previous studies have shown immediate benefits when children with congenital heart disease are enrolled in a cardiac rehabilitation (exercise) program. This study aimed to see if the benefits lasted after the exercise program ended. The results showed, compared with children who did not undergo cardiac rehabilitation after the Fontan procedure, children who did participate had significant improvements in exercise function, behavior, self-esteem and emotional state 6 months after their program ended.

    Read Publication

description

Fontan Follow-Up 2

(Observational Study)

This first follow-up to the Fontan study looked at how children and adolescents with single ventricle heart defects who participated in the Fontan Study were doing after their Fontan Surgery.

  • Survival data and predictors of functional outcome an average of 15 years after the Fontan procedure: The Pediatric Heart Network Fontan cohort

    A. Atz, Congenit Heart Dis 2015; 10(1):E30-42.

    Read Publication

  • The relationship of patient, medical and laboratory characteristics to changes in functional health status in children and adolescents after the Fontan procedure

    B. McCrindle, Pediatr Cardiol 2014; 35(4):632-640.

    Read Publication

  • Assessment of Quality of Life in Young Patients with Single Ventricle after the Fontan Operation

    K. Uzark, J Pediatr 2016; 170:166-172 Epub 2015 Dec 10.

    Read Publication

description

Fontan Follow-Up 3

(Observational Study)

This is a second follow-up study of an existing cohort of children. In this study we would like to learn how these children and young adults, who are now between the ages of 15 and 25 years, have done since their enrollment in Fontan 1.

  • Longitudinal outcomes of patients with Single Ventricle after the Fontan procedure

    A. Atz, J Am Coll Cardiol 2017; 69(22):2735-2744.

    Read Publication

  • Longitudinal study of anthropometry in Fontan survivors: Pediatric Heart Network Fontan study

    L. M. Lambert, Am Heart J. 2020 Jun;224:192-200. doi: 10.1016/j.ahj.2020.03.022.

    Read Publication

  • Exercise Capacity and Predictors of Performance After Fontan: Results from the Pediatric Heart Network Fontan 3 Study

    D. J. Goldberg, Pediatr Cardiol. 2020 Sep 25. doi: 10.1007/s00246-020-02465-1.

    Read Publication

description

FUEL/FUEL OLE/FALD/FUEL Perceptions

(RCT/open-label extension/ancillary studies)

In the FUEL study, we investigated whether taking a medication called udenafil for 6 months helps improve heart function in children who had a Fontan operation.

  • Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial

    D.J. Goldberg, Am Heart J. 2018 Jul; 201:1-8.

    This manuscript describes the design of the Fontan Udenafil Exercise Longitudinal (FUEL) trial. It is a trial comparing udenafil to placebo in children and adolescents with single ventricle heart disease who have undergone the Fontan operation. This study will examine changes in exercise capacity, heart performance, and vascular function. These outcomes are important in understanding whether udenafil may be a beneficial medication to maintain health for a longer period in this population.

    Read Publication

  • Results of the FUEL Trial

    D.J. Goldberg, Circulation. 2020 Feb 25;141(8):641-651.

    Read Publication

  • Impact of Udenafil on Echocardiographic Indices of Single Ventricle Size and Function in FUEL Study Participants

    M. V. DiMara, Circulation. 2022 Nov 15;15(11):e013676.

    The FUEL Echo study was an analysis of the echocardiograms (ultrasounds of the heart) that were performed as part of the FUEL trial. Before this study, it was not known how udenafil affected heart function in patients with a history of Fontan surgery. Overall, patients who received udenafil had improvement in some of the measurements of heart function and also heart filling. Because of the unique way that the Fontan operation works and the limits of what can be understood by ultrasound, more information will be needed to determine exactly how udenafil improves these measurements.

    Read Publication

description

Infant Single Ventricle (ISV)

(Enalapril vs Placebo Trial)

This study was done to see if giving a medication called Enalapril (an ACE inhibitor) would improve a baby's growth and heart function in the first year of life.

  • Enalapril in Infants with Single Ventricle: results of a multicenter randomized trial

    D. Hsu, Circulation 2010; 122:333-340.

    Read Publication

  • Rationale and Design of a Trial of Angiotensin-Converting Enzyme Inhibition in Infants With Single Ventricle

    D. Hsu, Am Heart J 2009; 157:37-45.

    Angiotensin-converting enzyme (ACE) inhibitors are medicines that improve heart function in adults with heart failure. Infants with a particular type of congenital heart defect (known as single ventricle) have been shown to have abnormal heart function and poor growth. This study was designed to determine if giving ACE inhibitors to babies with single-ventricles would improve their growth, heart function and development. This article describes the design, the participants and the procedures of this trial.

    Read Publication

  • Birth Weight and Prematurity in Infants With Single Ventricle Physiology: Pediatric Heart Network Infant Single Ventricle Trial Screened Population

    R. Williams, Congenit Heart Dis 2010; 5:96-103.

    Many congenital heart defects are associated with low birth weight and prematurity, but there is little information on birth characteristics of babies with a specific kind of defect, single ventricle physiology. This study compares birth parameters for babies enrolled in the Infant Single Ventricle Trial as compared to the typical US population. Infants with single ventricle had increased rates of preterm birth and low birth weight, and they were more likely to be small for gestational age than the general population.

    Read Publication

  • Renin-Angiotensin-Aldosterone Genotype Influences Ventricular Remodeling in Infants with Single Ventricle

    S. Mital, Circulation 2011; 123:2353-2362.

    Read Publication

  • Factors Impacting Growth in Infants with Single Ventricle Physiology: A Report from Pediatric Heart Network Infant Single Ventricle Trial

    R. Williams, J Pediatr 2011; 159:1017-22.

    Read Publication

  • Challenges and successes of recruitment in the “angiotensin-converting enzyme inhibition in infants with single ventricle trial” of the Pediatric Heart Network

    N. Pike, Cardiol Young 2013; 23(2): 248–257.

    Read Publication

  • Association of impaired linear growth and worse neurodevelopmental outcome in infants with single ventricle physiology: A report from the Pediatric Heart Network Infant Single Ventricle Trial

    C. Ravishankar, J Pediatr 2013; 162(2): 250–256.e2.

    Read Publication

  • Superior cavopulmonary anastomosis timing and outcomes in infants with single ventricle

    J. Cnota, J Thorac Cardiovasc Surg 2013; 145(5): 1288–1296.

    Read Publication

  • The association of fetal cerebrovascular resistance with early neurodevelopment in single ventricle congenital heart disease

    I. Williams, Am Heart J 2013; 165(4):544-550.e1.

    Read Publication

  • The Impact of CNVs on Outcomes for Infants with Single Ventricle Heart Defects

    A. S. Carey, Circ Cardiovasc Genet. 2013 Oct; 6(5): 444–451.

    Read Publication

  • Factors Associated with Serum B- type Natriuretic Peptide Levels in Infants with Single Ventricle

    R. Butts, Pediatr Cardiol 2014; 35(5):879-87.

    Read Publication

  • Validation of association of the apolipoprotein E ε2 allele with neurodevelopmental dysfunction after cardiac surgery in neonates and infants

    J. W. Gaynor, J Thorac Cardiovasc Surg. 2014 Dec;148(6):2560-6.

    Read Publication

  • Neurodevelopmental outcomes after cardiac surgery in infancy

    J. Gaynor, Pediatrics 2015; 135(5):816-25.

    Read Publication

  • Growth Asymmetry, Head Circumference, and Neurodevelopmental Outcomes in Infants with Single Ventricles

    T. Miller, J Pediatr 2016; 168:220-225.

    Read Publication

  • The Effect of the Superior Cavopulmonary Anastomosis on Ventricular Remodeling in Infants with Single Ventricle

    R. Margossian, J Am Soc Echocardiogr 2017; 130(7):699-707.e1.

    Read Publication

  • Translating clinical trials into clinical practice: a survey assessing the potential impact of the Pediatric Heart Network Infant Single Ventricle Trial

    V. Zak, Cardiol Young 2017; 27(7):1265-1270.

    Read Publication

description

Integrated CARdiac Data and Outcomes (iCARD) Collaborative

(PHN Landmark Publication)

The Pediatric Heart Network developed the Integrated CARdiac Data and Outcomes (iCARD) Collaborative with the goals of leveraging available data sources to aid in efficiently planning and conducting PHN studies; supporting integration of PHN data with other sources to foster novel research otherwise not possible; and mentoring young investigators in these areas.

  • Enhancing efficiency and scientific impact of a clinical trials network: the Pediatric Heart Network Integrated CARdiac Data and Outcomes (iCARD) Collaborative

    S. K. Pasquali, Cardiol Young. 2019 Sep;29(9):1121-1126.

    Read Publication

description

Kawasaki Disease

(Methylprednisolone vs Placebo Trial)

This study evaluated pulse steroid therapy in kawasaki disease (KD). The purpose of this trial was to see if adding steroids (methylprednisone) to the standard treatment would improve coronary artery outcomes.

  • Randomized Trial of Pulsed Corticosteroid Therapy for Primary Treatment of Kawasaki Disease

    J. Newburger, N Engl J Med 2007; 356(7):663-675.

    Children with Kawasaki Disease (KD) are at risk for developing aneurysms (out-pouchings) and enlargement of the coronary arteries, the arteries which bring blood and oxygen to the heart muscle itself. Medications are used to reduce the risk of damage to the coronary arteries and to decrease inflammation. Yet, some children still develop aneurysms and coronary artery enlargement. This trial tested whether adding another type of medication (a corticosteroid) to the standard treatment of aspirin and immune globulin would decrease the amount of coronary artery dilation. The results did not support the use of a steroid in addition for the routine treatment of children with KD.

    Read Publication

  • Treatment of Kawasaki Disease: Response to Letter to the Editor

    J. Newburger, N Engl J Med 2007; 356(26):2748.

    Read Publication

  • Delayed Diagnosis of Kawasaki Disease: What Are the Risk Factors?

    L. Minich, Pediatrics 2007; 120(6):e1434-40.

    Late diagnosis of Kawasaki Disease (KD) increases the risk that a child might have enlargement or aneurysms (out-pouching) of their coronary arteries. This study tried to see how many children in the KD study had a late diagnosis and what factors contributed to a late diagnosis. Being less than 6 months of age, living a greater distance from the hospital and having fewer symptoms (incomplete KD) increased the likelihood of late diagnosis.

    Read Publication

  • Coronary Artery Involvement in Children with Kawasaki Disease: Risk Factors from Analysis of Serial Normalized Measurements

    B. McCrindle, Circulation 2007; 116:1-6.

    This study looked at how coronary artery size changes during when a child has Kawasaki Disease (KD) by performing echocardiograms at the time of diagnosis, at one week and five weeks after diagnosis. The results showed that, in most patients, the coronary arteries are most dilated at the time of diagnosis of KD and they decrease in size over time. The KD study also showed that aneurysms (bulges or outpouches) in the coronary arteries were infrequent.

    Read Publication

  • Associated Symptoms in the Ten Days Before Diagnosis of Kawasaki Disease

    A. Baker, J Pediatr 2009; 154(4):592-595.

    Many children with Kawasaki disease (KD) have other symptoms that may lead to a delay in the diagnosis of KD. This study investigated common symptoms in children in the KD study (in addition to the symptoms of KD) in the 10 days before they were diagnosed with KD. Symptoms reported were irritability, vomiting, decrease in food/fluid intake, coughing, diarrhea, runny nose, weakness, stomach pain, and joint pain. Symptoms of KD can often be accompanied by symptoms commonly found in other common childhood illnesses. Clinicians should consider the diagnosis of KD, even when other common symptoms are present.

    Read Publication

  • Non-Coronary Cardiac Abnormalities are Associated with Coronary Artery Dilation and with Laboratory Inflammatory Markers in Acute Kawasaki Disease

    B. Printz, J Am Coll Cardiol 2011; 57:86-92.

    Read Publication

  • Evaluation of Kawasaki Disease Risk Scoring Systems for Intravenous Immunoglobulin Resistance

    L. Sleeper, J Pediatr 2011; 158:831-5.

    Read Publication

  • Predictors of coronary artery visualization in Kawasaki disease

    R. Margossian, J Am Soc Echocardiogr 2011; 24(1):53-9.

    Read Publication

description

Marfan

(Atenolol vs Losartan Trial)

This study was done to compare two drugs (Atenolol and Losartan) to see if one is better than the other at slowing the speed of aortic enlargement. The study also compared the kinds of side effects that can occur when taking either of these medicines.

  • Atenolol versus Losartan in Children and Young Adults with Marfan’s Syndrome

    R. Lacro, N Engl J Med 2014; 371:2061-2071.

    Among 608 children and young adults with Marfan’s syndrome (ages 6 months to 26 years) who were randomly assigned to losartan or atenolol, we found no significant difference in the rate of aortic-root dilatation between the two treatment groups over a 3-year period. Aortic-root surgery, aortic dissection, death, and a composite of these events did not differ significantly between the two treatment groups.

    Read Publication

  • Rationale and Design of a Randomized Clinical Trial of B-Blocker Therapy (Atenolol) Versus Angiotensin II Receptor Blocker Therapy (Losartan) in Individuals with Marfan Syndrome

    R. Lacro, Am Heart J 2007; 154:624-631.

    The leading cause of death in people with Marfan syndrome is dilation, tearing and rupture of the aorta, the large artery that delivers blood from the heart to the body. Recent studies in mice with Marfan syndrome showed that treatment with Losartan, a medication used to treat high blood pressure, prevented dilation and improved the structure of the wall of the aorta. This article describes the design of a trial to compare Losartan to the standard medication (Atenolol) for patients with Marfan syndrome. The goal of the trial is to follow over 600 children and young adults for 3 years to determine which drug does a better job slowing the rate of growth of the aorta.

    Read Publication

  • Echocardiographic Methods, Quality Review, and Measurement Accuracy in a Randomized Multicenter Clinical Trial of Marfan Syndrome

    E. Selamet Tierney, J Am Soc Echocardiogr 2013; 26(6):657-666.

    This study describes the characteristics of the echocardiograms for subjects enrolled in the clinical trial. Even when different doctors reviewed and measured the aortas and heart structures of the trial participants, there was excellent agreement in the measurements. Having good agreement is important for accurately reporting the results of the clinical trial.

    Read Publication

  • Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy

    R. Lacro, Am Heart J 2013; 165:828-835.e3.

    This paper describes the population that was screened and then enrolled in the clinical trial. The average age at study entry was 11.2 years, 60% were male, and 25% were older teenagers and young adults. Aortic root diameter z-score was 4.0 and wasn’t different by age. Mitral valve prolapse and mitral regurgitation were more common in females. 56% had a family member with aortic surgery and 32% had a family member with a history of aortic dissection.

    Read Publication

  • Influence of Aortic Stiffness on Aortic-Root Growth Rate and Outcome in Patients With the Marfan Syndrome

    ES. Selamet Tierney, Am J Cardiol 2018 May 1;121(9):1094-1101.

    The PHN randomized trial of atenolol versus losartan in Marfan Syndrome showed no treatment differences in the rates of aortic-root growth or clinical outcomes. This analysis examined treatment effects on aortic stiffness and determined whether baseline aortic stiffness predicts aortic-root growth and clinical outcomes. There was no treatment effect on the rate of change for ascending-aorta stiffness index, aortic-root elastic modulus, or ascending-aorta elastic modulus. We found that atenolol therapy was associated with a fall in aortic-root stiffness index, while losartan therapy was not. Higher baseline aortic-root stiffness index and elastic modulus were associated with a smaller decrease in aortic root z-score and increased risk for clinical outcomes. These data suggest that non-invasive aortic stiffness measures may identify patients at higher risk for progressive aortic enlargement and adverse clinical outcomes, potentially allowing for closer monitoring and more aggressive therapy for such patients.

    Read Publication

  • Predictors of Rapid Aortic Root Dilation and Referral for Aortic Surgery in Marfan Syndrome

    A. Hoskoppal, Pediatr Cardiol 2018 Jun 11. doi: 10.1007/s00246-018-1916-6.

    This was a secondary analysis of the PHN randomized clinical trial of atenolol vs. losartan in patients with Marfan syndrome that attempted to identify factors that predict rapid aortic root dilation and referral for aortic surgery. We found some statistically significant but only weakly predictive associations between more rapid aortic root dilation and older age, non-white race, and one aortic measurement: higher sinotubular junction z-score. We found similarly statistically significant but only weakly predictive associations between referral for aortic root surgery and some aortic measurements (larger aortic root diameter, higher ascending aorta z-score, and higher ratio between the diameters of the sinotubular junction and ascending aorta). Future studies may clarify whether monitoring generalized proximal aortic dilation and effacement of the sinotubular junction will help to risk-stratify young patients with Marfan syndrome and inform medical and surgical management.

    Read Publication

  • Frequency of Ventricular Arrhythmias and Other Rhythm Abnormalities in Children and Young Adults With the Marfan Syndrome

    D. Y. Mah, Am J Cardiol. 2018 Jul 17. pii: S0002-9149(18)31424-3. doi: 10.1016/j.amjcard.2018.07.006.

    Read Publication

  • Health-Related Quality of Life in Children and Young Adults with Marfan Syndrome

    J. C. Handisides, J Pediatr. 2019 Jan;204:250-255.e1. doi: 10.1016/j.jpeds.2018.08.061.

    Read Publication

  • Variants in ADRB1 and CYP2C9: Association with Response to Atenolol and Losartan in Marfan Syndrome.

    S. Driest, J Pediatr. 2020 Jul;222:213-220.e5. doi: 10.1016/j.jpeds.2020.03.064.

    Read Publication

  • Recruitment, retention, and adherence in a clinical trial: The Pediatric Heart Network’s Marfan Trial experience

    M. S. Hamstra, Clin Trials 2020 Aug 21;1740774520945988. doi: 10.1177/1740774520945988.

    Read Publication

  • Molecular characterization and investigation of the role of genetic variation in phenotypic variability and response to treatment in a large pediatric Marfan syndrome cohort

    J. A. N.  Meester, Genetics in Medicine 2022 Jan. doi: 10.1016/j.gim.2021.12.015.

    The purpose of our study was first to identify how many people with Marfan syndrome in the study have a mutation in the FBN1 gene. Afterwards, we investigated if the type of FBN1 mutation is associated with specific symptoms and whether the type of mutation made the treatment work any better or worse. In total, 373 young patients with Marfan syndrome participated in our study. We identified an FBN1 mutation in 91% of participants in our study. A dislocated eye lens happened more often in participants with dominant-negative gene mutations (which are mutations that lead to an abnormal protein) than in those with haplo-insufficient mutations (which are mutations that lead to  lower levels of normal protein). In participants with a dominant negative mutation, a dislocation of the eye lens happened more often if the mutation was located at the beginning of the protein (84%) than if the mutation was found towards the end of the protein (17%). If a dominant negative mutation was present in the middle of the protein, the participants had more severe cardiovascular symptoms. We could not prove whether the type of mutation made treatment work any better. In conclusion, we described new links between the type of gene mutation and symptoms in Marfan syndrome. Our findings will provide more information for families with Marfan syndrome about their condition.

    Read Publication

  • Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials

    A. Pitcher, Lancet 2022 Aug. doi: 10.1016/S0140-6736(22)01534-3.

    People with Marfan syndrome may have enlargement of the aortic root, and medications are often used to try to slow the rate of enlargement. This study combined data from 7 trials and 1442 patients with Marfan syndrome to see whether two types of medications (angiotensin receptor blockers and β blockers) could slow the rate of enlargement of the aortic root. The study found that, in people with Marfan syndrome and no previous aortic surgery, angiotensin receptor blockers reduced the rate of increase of the aortic root by about one half, even among those who were already taking a β blocker. The effects of β blockers were similar to those of angiotensin receptor blockers. They concluded that a combination of a β blocker and an angiotensin receptor blocker could reduce the rate of enlargement of the aortic root by at least one half, and potentially by much more than this, which may delay the need for aortic surgery.

    Read Publication

description

Mitral Regurgitation

(Observational Study)

This was a study of ACE inhibition therapy in children with mitral regurgitation (MR) after Repair of an Atrioventricular Septal Defect (AVSD).

  • Partial and Transitional Atrioventricular Septal Defect Outcomes

    L. Minich, Ann Thorac Surg 2010; 89:530-536.

    There have been many improvements in the surgery and care of children with atrioventricular septal defects (AVSD. This article describes the outcomes at 1 and 6 months after repair for children with two particular types of AVSD: partial and transitional AVSDs. Children had short hospital stays and few adverse events around the time of surgery. Also, children who were growing poorly before surgery showed good catch-up growth if the surgery was performed between 3 and 18 months of age. Some children have leaking of the left-sided atrioventricular valve after surgery, particularly if surgery is performed after age four.

    Read Publication

  • Lessons learned from a pediatric clinical trial: The Pediatric Heart Network Angiotensin Converting Enzyme Inhibition in Mitral Regurgitation Study

    J. Li, Am Heart J 2011; 161:233-40.

    The Pediatric Heart Network designed a placebo-controlled randomized trial to test the effect of enalapril on the amount of left heart valve regurgitation after atrioventricular septal defect (AVSD) repair. Prior to the launch of the trial, a feasibility study was performed to estimate the number of patients with at least moderate mitral regurgitation following AVSD repair. The study was subsequently terminated due to low patient accrual. Several factors led to the problems with enrolling patients: 1) the feasibility study used chart review to assess for valve regurgitation but the trial used echocardiography measurements; 2) clinicians and referring physicians were already believing that enalapril was a good drug to give and many patients eligible for the study were already taking the drug; 3) the echocardiography methods used were developed in adult populations and not children; 4) there are no good data to define the natural history of the disease process.

    Read Publication

  • Surgical management of complete atrioventricular septal defect: Associations with surgical technique, age and Trisomy 21

    A. Atz, J Thorac Cardiovasc Surg 2011; 141:1371-9.

    This study evaluated contemporary results after repair of a complete atrioventricular septal defect (AVSD) and to determine factors associated with poorer outcomes. Particular attention was paid to type of surgical repair, age at surgery, and presence of Trisomy 21. The type of surgical repair and having Trisomy 21 did not increase the risk of death or serious medical problems. Mortality and morbidity were low. Age at repair ≤2.5 months and need for concurrent surgical procedures were not associated with residual defects or degree of heart valve regurgitation, but were associated with higher resource utilization.

    Read Publication

  • Surgical interventions for Atrioventricular Septal defect subtypes: The Pediatric Heart Network experience

    A. Kaza, Ann Thorac Surg 2011;92:1468-75.

    Atrioventricular septal defects (AVSD) include abnormalities involving the walls between the heart chambers (atrial and ventricular septa) and the heart valves. The investigators compared patient characteristics, resource utilization, center differences, and outcomes among different types of AVSD. Survival in the current era is excellent, with few residual defects after surgical repair for all AVSD subtypes. Repair of the valves failed to decrease moderate or severe valve regurgitation at the 6-month follow-up. Being older when the heart is repaired increases the risk of moderate or severe valve regurgitation.

    Read Publication

  • Challenges in echocardiographic assessment of mitral regurgitation in children after repair of Atrioventricular Septal Defect

    A. Prakash, Pediatr Cardiol 2012; 33:205-214.

    It is difficult to quantify the amount of regurgitation from the mitral valve using echocardiography. Since children who have an atrioventricular septal defect repaired continue to have varying amounts of mitral regurgitation, the accuracy of proposed echocardiographic methods was proposed to evaluate the severity of the regurgitation. No method performed well. No method proved to be better than the echocardiographer’s subjective assessment of the size of the color Doppler jet and surrounding structures. Reliable assessment of mitral regurgitation remains challenging in this population.

    Read Publication

description

MUSIC

(Observational)

MIS-C is a new condition related to COVID-19, so we are still learning about its causes and effects. This study will help us learn more about MIS-C and its effects on long-term health of children.

  • The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives

    D. T. Truong, American Heart Journal. 2022 Jan; 243:43-53.

    Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare, but serious, complication of COVID-19 in people who are younger than 21 years-old. The illness causes inflammation and injury to various organs, including the heart. The “Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC)” study was developed to better understand the recovery of the heart and other organ systems in children, adolescents, and young adults with MIS-C. The publication “The NHLBI  Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives” describes reasoning and the methods for the MUSIC study. The goals of the study include understanding the timing of recovery of the squeeze of the heart and of enlargement of the coronary arteries (small blood vessels that bring oxygen to the heart). Other goals of the study are to describe how MIS-C affects other organs and their recovery over time, as well as monitor for development of new symptoms over time. The study plans to enroll at least 600 participants across 33 North American pediatric hospitals. The study will collect data from participants’ hospitalization and follow the participants for up to 5 years using a yearly medical questionnaire about general health, the heart, and all the organ systems.

    Read Publication

  • Examination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children

    M. D. Elias, JAMA Network Open. 2023 Jan 3;6(1):e2248987.

    The multisystem inflammatory syndrome in children (MIS-C) is a complication of COVID-19, and it can cause heart issues among children. The COVID-19 vaccine can prevent children from being very sick with COVID. Some families and providers worry about the risks of the vaccine after MIS-C. This study evaluated reactions to the vaccine after MIS-C. There were no serious complications reported among 185 children. Many reported minor side effects (fatigue, arm soreness) similar to the general public.

    Read Publication

description

Passive Range of Motion (TEAM 4 Growth) Pilot

(Observational Study)

The purpose of this study was to see if a program of gentle physical exercise is safe and helps babies to grow after having surgery to repair their hearts.

  • Passive range of motion exercise to enhance growth in infants following the Norwood procedure: a safety and feasibility trial

    L.M. Lambert, Cardiol Young 2017; 27(7):1361-1368.

    This non-randomized pilot study enrolled 20 neonates after surgery for heart repair. The aim was to evaluate the safety and feasibility of a passive range of motion exercise program, administered by trained physical therapists for up to 21 days or until hospital discharge. We found the exercise program to be safe for babies with complex congenital heart disease after surgery and feasible to perform.

    Read Publication

description

PHN Scholars

(PHN Landmark Publication)

The PHN Scholar Program is a career development program to train the next generation of clinician-scientists in pediatric cardiology-related research, a historically underfunded area. The program awards study grants to support outstanding researchers in the field of translational, clinical, health services, or epidemiological pediatric cardiovascular disease or adult congenital heart disease.

  • The Pediatric Heart Network Scholar Award programme: a unique mentored award embedded within a multicentre network

    L.L. Minich, Cardiol Young 2018 Jun;28(6):854-861.

    The Pediatric Heart Network designed a career development award to train the next generation of clinician-scientists in pediatric cardiology-related research, a historically underfunded area. This manuscript described strengths and weaknesses of the program and the scholars’ academic achievements for the first two funding cycles. Strengths included clarity and fairness of the review, but feedback on the application was not considered useful. The highest rated benefits were expanding the scholar’s collaborative network and increasing publication potential. The 13 scholars were first/senior authors for 97 abstracts and 109 manuscripts, served on 22 PHN committees, and were awarded $9,673,660 in subsequent extramural funding for a return of ~$10 for every Scholar dollar spent.

    Read Publication

description

Residual Lesion Score (RLS)

(Observational Study)

The aim of this research was to study whether a scoring system called the Residual Lesion Score could predict how children with congenital heart disease do after cardiac surgery.

  • Completeness and Accuracy of Local Clinical Registry Data for Children Undergoing Heart Surgery

    M. Nathan, Ann Thorac Surg 2016 Oct 7. pii: S0003-4975(16)30916-X.

    The purpose of this study was to assess the accuracy of heart surgery data obtained from a registry compared with data copied from babies’ medical charts by research coordinators. Most PHN sites participate in a registry called “the Society of Thoracic Surgeons- Congenital Heart Surgery Database” in which each site collects data around the time of surgeries. For a select set of variables (like blood pressure, length of hospital stay etc), we found that 94.7% of data elements were both complete and accurate within the registry, suggesting that registry data can be an efficient source for research studies.

    Read Publication

  • The Pediatric Heart Network Residual Lesion Score Study: Design and Objectives

    M. Nathan, J Thorac Cardiovasc Surg 2019 Nov 15. pii: S0022-5223(19)32761-8.

    Outcomes after surgery for congenital heart disease may be impacted by a wide variety of variables. Risk for adverse outcomes begins before surgery and includes innate characteristics such as birth weight, gestational age, genetic abnormalities, and complexity of congenital heart disease (CHD), as well as factors such as hemodynamic stability, adequacy of diagnostic evaluation, prior cardiac operation(s), and appropriateness of surgical plan. Intraoperative risk factors relate to cardiopulmonary bypass, surgical technique, adequacy of intraoperative imaging, subsequent decision to return (or not) to bypass for residual lesions identified, and early post-bypass hemodynamic management. The postoperative milieu may also contribute to outcomes, particularly through serious medical events and complications. The presence of residual lesions (intended or unintended postoperative structural cardiac abnormalities, including those persisting from the preoperative state or newly acquired consequent to the surgical procedure) may be among the most important factors in determining long-term clinical outcomes and costs. The “Residual Lesion Score” (RLS) is a novel tool for evaluating the status of repair across operations and centers. The prospective multi-center RLS study, funded by the National Heart Lung and Blood Institute’s Pediatric Heart Network (PHN), seeks to validate the association of the RLS with early and mid-term postoperative outcomes for common congenital cardiac operations in a multicenter environment. The RLS can serve as an instrument for quality improvement and support future research on perioperative strategies to improve outcomes of congenital heart surgery.

    Read Publication

  • Lessons learned in the use of clinical registry data in a multi-centre prospective study: the Pediatric Heart Network Residual Lesion Score Study

    C. J. Prospero, Cardiol Young. 2019 Jul;29(7):930-938.

    Read Publication

  • Registry-based trials: a potential model for cost savings?

    B. R. Anderson, Cardiol Young. 2020 Jun;30(6):807-817.

    Read Publication

description

SAXOPHONE

(Phase 2, open-label 2:1 randomized trial of apixaban vs. standard of care)

The purpose of this study was to find out whether the medicine called apixaban (commonly known as Eliquis®) is safe for children with heart disease, and to learn how much apixaban will be present in the blood after taking a certain dose.

  • A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study

    R. M. Payne, Am Heart J. 2019 Nov;217:52-63.

    Read Publication

description

Single Ventricle Reconstruction (SVR)

(RV-PA Shunt vs MBT Shunt Trial)

The Single Ventricle Reconstruction (SVR) Trial was done to evaluate two commonly placed shunts to see which one would improve how patients do following the Norwood procedure.

  • Comparison of Shunt Types in the Norwood Procedure for Single-Ventricle Lesions

    R. Ohye, N Engl J Med 2010; 362(21):1980-1992.

    In children with a single heart ventricle undergoing the Norwood procedure, a trial was conducted to determine if one of two different shunts resulted in better survival after 12 months without the need for a heart transplant. Babies were randomly assigned to receive either the traditional modified Blalock-Taussig shunt (MBTS) or the right ventricle- pulmonary artery (RV-PA) conduit. The study showed that babies who received the RV-PA conduit had better survival without needing a heart transplant 12 months after entering the study. However, when the babies were followed for a longer period of time, there was no difference between the two groups. The results also revealed that babies who received the RV-PA conduit needed more procedures and had more complications than those receiving the MBTS.

    Read Publication

  • Design and Rationale of a Randomized Trial Comparing the Blalock-Taussig and Right Ventricle-Pulmonary Artery Shunts in the Norwood Procedure

    R. Ohye, J Thorac Cardiovasc Surg 2008; 136:968-975.

    The first of the three surgeries (the Norwood procedure) for babies born with a single heart ventricle is one of the highest risk procedures in congenital heart surgery. Two types of shunts (tubes) may be used for the first surgery: the traditional modified Blalock-Taussig shunt (MBTS) and the right ventricle to pulmonary artery (RV-PA) shunt. Some research has shown one technique to be better than the other, but other research has shown no differences in the outcomes for each technique. This article describes a trial designed by the Pediatric Heart Network to compare the two types of shunts. In the study, babies were randomly assigned to receive either the MBTS or the RV-PA shunt, and they were followed over time to compare the outcomes.

    Read Publication

  • The Modified Blalock-Taussig Shunt Versus the Right Ventricle-to-Pulmonary Artery Conduit for the Norwood Procedure

    R. Ohye, Pediatr Cardiol 2007; 28:122-125.

    Babies born with a single heart ventricle require multiple surgeries in order to provide adequate blood flow to the body. The first of the three surgeries is one of the highest risk procedures in congenital heart surgery. Two types of shunts (tubes) may be used for the first surgery: the traditional modified Blalock-Taussig shunt (MBTS) and the right ventricle to pulmonary artery (RV-PA) shunt. This article explains the advantages and disadvantages of each shunt and the Pediatric Heart Network’s clinical trial to determine if one shunt type is better than another in this population (see results of the PHN trial).

    Read Publication

  • Prenatal Diagnosis and Risk Factors for Preoperative Death in Neonates with Single Right Ventricle and Systemic Outflow Obstruction: Screening Data from the Pediatric Heart Network Single Ventricle Reconstruction Trial

    A. Atz, J Thorac Cardiovasc Surg 2010; 140:1245-1250.

    Read Publication

  • Celiac Artery Flow Pattern in Infants with Single Right Ventricle Following the Norwood Procedure with a Modified Blalock-Taussig or Right Ventricle to Pulmonary Artery Shunt

    J. Johnson, Pediatr Cardiol 2011; 32:479-486.

    Read Publication

  • Reporting adverse events in a surgical trial for complex congenital heart disease: The Pediatric Heart Network Experience

    L. Virzi, J Thorac Cardiovasc Surg 2011; 142(3): 531-537.

    Read Publication

  • Early neurodevelopmental outcome in hypoplastic left heart syndrome and related anomalies: The Single Ventricle Reconstruction Trial

    J. Newburger, Circulation 2012; 125:2081-2091.

    Read Publication

  • Intermediate-term mortality and cardiac transplantation in infants with single-ventricle lesions: Risk factors and their interaction with shunt type

    J. Tweddell, J Thorac Cardiovasc Surg 2012; 144(1):152-159.e2.

    Read Publication

  • Does initial shunt type for the Norwood procedure affect echocardiographic measures of cardiac size and function during infancy? The Single Ventricle Reconstruction Trial

    P. Frommelt, Circulation 2012; 125:2630-2638.

    Read Publication

  • Variation in perioperative care across centers for infants undergoing the Norwood procedure

    S. Pasquali, J Thorac Cardiovasc Surg 2012; 144:915-21.

    Read Publication

  • Risk factors for hospital morbidity and mortality after the Norwood procedure: A report from the Pediatric Heart Network Single Ventricle Reconstruction Trial

    S. Tabbutt, J Thorac Cardiovasc Surg 2012; 144:882-95.

    Read Publication

  • Interstage mortality after the Norwood Procedure: Results of the multicenter Single Ventricle Reconstruction Trial

    N. Ghanayem, J Thorac Cardiovasc Surg 2012; 144:896-906.

    Read Publication

  • Cause, timing and location of death in the Single Ventricle Reconstruction trial

    R. Ohye, J Thorac Cardiovasc Surg 2012; 144:907-14.

    Read Publication

  • Introduction to the Single Ventricle Reconstruction trial

    E. Bacha, J Thorac Cardiovasc Surg 2012; 144(4): 880-1.

    Read Publication

  • A Predictive Model for Neurodevelopmental Outcome Following the Norwood Procedure

    W. Mahle, Pediatr Cardiol 2013; 34(2):327-333.

    Read Publication

  • Doppler flow patterns in the right ventricle-to-pulmonary artery shunt and neo-aorta in infants with single right ventricle anomalies – Impact on outcome after initial staged palliations

    P. Frommelt, J Am Soc Echocardiogr 2013; 26:521-9.

    Read Publication

  • Intervention for re-coarctation in the Single Ventricle Reconstruction Trial: Incidence, risk and outcomes

    K. Hill, Circulation 2013; 128(9): 10.1161/CIRCULATIONAHA.112.000488.

    Read Publication

  • A multi-center study comparing shunt type in the Norwood procedure for single-ventricle lesions: 3-Dimensional echocardiographic analysis

    G. Marx, Circ Cardiovasc Imaging 2013; 6(6): 934–942.

    Read Publication

  • Risk factors for prolonged length of stay following stage 2 procedure in the Single-Ventricle Reconstruction Trial

    S. Schwartz, J Thorac Cardiovasc Surg 2014; 147(6):1791-8, 1798.e1-4.

    Read Publication

  • Variation in Feeding Practices Following the Norwood Procedure

    L. Lambert, J Pediatr 2014; 164(2): 237–242.e1.

    Read Publication

  • Technical performance score is associated with outcomes after the Norwood procedure

    M. Nathan, J Thorac Cardiovasc Surg. 2014 Nov;148(5):2208-13, 2214.e1-6.

    Read Publication

  • Impact of pre-stage II hemodynamics and pulmonary artery anatomy on 12-month outcome in the Single Ventricle Reconstruction Trial

    R. Aiyagari, J Thorac Cardiovasc Surg 2014; 148(4):1467-74

    Read Publication

  • Associations Between Day of Admission and Day of Surgery on Outcome and Resource Utilization in Infants With Hypoplastic Left Heart Syndrome Who Underwent Stage I Palliation (from the Single Ventricle Reconstruction Trial)

    J. Johnson, Am J Cardiol 2015; 116(8):1263-9.

    Read Publication

  • Impact of Initial Norwood Shunt Type on Right Ventricular Deformation: The Single Ventricle Reconstruction Trial

    G. D. Hill, J Am Soc Echocardiogr. 2015 May; 28(5): 517–521.

    Read Publication

  • The Single Ventricle Reconstruction Trial: The data goes public

    S. Bradley, J Thorac Cardiovasc Surg 2016; 152(1):195-6.

    Read Publication

  • Heart block following stage 1 palliation of hypoplastic left heart syndrome

    D. Mah, J Thorac Cardiovasc Surg 2016; 152(1):189-94.

    Read Publication

  • Intraoperative Steroid Use and Outcomes Following the Norwood Procedure: An Analysis of the Pediatric Heart Network’s Public Database

    J. Elhoff, Pediatr. Crit. Care Med 2016; 17(1):30-5.

    Read Publication

  • Association of Digoxin With Interstage Mortality: Results From the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Use Dataset

    M. Oster, J Am Heart Assoc 2016; 13;5(1). pii: e002566.

    Read Publication

  • Impact of Operative and Postoperative Factors on Neurodevelopmental Outcomes After Cardiac Operations

    International Cardiac Collaborative on Neurodevelopmental (ICCON) Investigators. Ann Thorac Surg. 2016; 102(3):843-849.

    Read Publication

  • Outcomes and risk factors for listing for heart transplantation after the Norwood procedure: An analysis of the Single Ventricle Reconstruction Trial

    A. Kulkarni. J Heart Lung Transplant. 2016 Mar;35(3):306-311.

    Read Publication

  • Impact of postoperative complications on hospital costs following the Norwood operation

    K. E. McHugh. Cardiol Young. 2016 Oct;26(7):1303-9.

    Read Publication

  • Adrenergic receptor genotypes influence postoperative outcomes in infants in the Single-Ventricle Reconstruction Trial

    R. Ramroop, J Thorac Cardiovasc Surg. 2017; 154(5):1703-1710.e3.

    Read Publication

  • Development and impact of arrhythmias after the Norwood procedure: A report from the Pediatric Heart Network

    M.E. Oster, J Thorac Cardiovasc Surg 2017 Mar;153(3):638-645.e2.

    Read Publication

  • Encrypted prediction: A hacker’s perspective

    T. Karamlou, J Thorac Cardiovasc Surg 2017 Dec;154(6): 2038-2040.

    Read Publication

  • A prognostic tool to predict outcomes in children undergoing the Norwood operation

    P. Gupta, J Thorac Cardiovasc Surg 2017 Dec;154(6):2030-2037.e2.

    Read Publication

  • The optimal timing of Stage-2-Palliation for Hypoplastic Left Heart Syndrome: An analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial public dataset

    J. M. Meza, Circulation. 2017 Oct 31; 136(18): 1737–1748.

    Read Publication

  • Cost Variation Across Centers for the Norwood Operation

    K. E. McHugh, Ann Thorac Surg. 2018 Mar; 105(3): 851–856.

    Read Publication

  • Survival to Stage II with Ventricular Dysfunction: Secondary Analysis of the Single Ventricle Reconstruction Trial

    E. Jean-St-Michel, Pediatr Cardiol 2018 Jun;39(5):955-966.

    Read Publication

  • The Impact of the Left Ventricle on Right Ventricular Function and Clinical Outcomes in Infants with Single-Right Ventricle Anomalies up to 14 Months of Age

    M.S. Cohen, J Am Soc Echocardiogr. 2018 Jul 3. pii: S0894-7317(18)30249-9.

    We assessed whether left ventricular size and function influence right ventricular function and clinical outcomes after staged palliation for single right ventricle anomalies. In the Single Ventricle Reconstruction (SVR) trial cohort, we studied left ventricle size and function compared to echocardiography-derived measures of right ventricular size and function as well as tricuspid regurgitation. We also assessed the impact of the left ventricle on outcome (death and/or heart transplantation). The hypoplastic left heart syndrome subtype of aortic atresia/mitral atresia was less likely to have a measurable left ventricle compared to other subtypes. Right ventricle end-diastolic and end-systolic volumes were significantly larger, while diastolic indices suggested better properties in those subjects with no measurable left ventricle compared to those with measurable ventricles. Right ventricular ejection fraction and tricuspid regurgitation were not different based on left ventricle size and function. There was no difference between groups in transplantation-free survival up to 14 months of age. In patients with single right ventricle anomalies, left ventricular size and function has a minimal short-term impact on survival and right ventricular performance.

    Read Publication

  • Oxygen saturations and neurodevelopmental outcomes in single ventricle heart disease

    K. R. Wolfe, Pediatr Pulmonol. 2019 Jun;54(6):922-927.

    Read Publication

  • Prevalence and associated factors of post-traumatic stress disorder in parents whose infants have single ventricle heart disease

    J. Bainton, Cardiology in the Young. 2023 Jan 5; 1-10.

    Post-traumatic stress disorder occurs in parents of infants with CHD, contributing to psychological distress with detrimental effects on family functioning and well-being. We sought to determine the prevalence and factors associated with post-traumatic stress disorder symptoms in parents whose infants underwent staged palliation for single ventricle heart disease. The study population included 215 mothers and fathers who were assessed for symptoms of post-traumatic stress disorder at three timepoints, including post Norwood, post-Stage II, and a final study timepoint when the child reached approximately 16 months of age, using the self-report questionnaire Impact of Event Scale – Revised. The prevalence of probable post-traumatic stress disorder post-Norwood surgery was 50% of mothers and 39% of fathers, decreasing to 27% of mothers and 24% of fathers by final follow-up. Intrusive symptoms such as flashbacks and nightmares and hyperarousal symptoms such as poor concentration, irritability, and sudden physical symptoms of racing heart and difficulty breathing were particularly elevated in parents. Higher levels of anxiety, reduced coping, and decreased satisfaction with parenting were significantly associated with symptoms of post-traumatic stress disorder in parents. Demographic and clinical variables such as parent education, pre-natal diagnosis, medical complications, and length of hospital stay(s) were not significantly associated with symptoms of post-traumatic stress disorder. Parents whose infants underwent staged palliation for single ventricle heart disease often reported symptoms of post-traumatic stress disorder. Symptoms persisted over time and routine screening might help identify parents at-risk and prompt referral to appropriate supports.

    Read Publication

description

Single Ventricle Reconstruction Follow-Up 2 (SVR II)

(Observational Study)

In this first follow-up to the SVR Trial, we wanted to learn if these same children (2-6 years of age) do better with one of the two shunts (RV-to-PA or MBTS) in the years after surgery. We also explored how other medical and surgical factors affect children's health and how they develop.

  • Transplantation-free survival and interventions at 3 years in the single ventricle reconstruction trial

    J. Newburger, Circulation 2014; 129:2013-2020.

    In the Single Ventricle Reconstruction (SVR) trial, 1-year transplant-free survival was better for the Norwood procedure with right ventricle-to-pulmonary artery shunt (RVPAS) compared with a modified Blalock-Taussig shunt (MBTS). At 3 years, we compared transplantation-free survival, echocardiographic right ventricular ejection fraction, and unplanned interventions in the treatment groups. By 3 years, the Norwood procedure with RVPAS compared with MBTS was no longer associated with better transplant-free survival. Moreover, RVPAS subjects had slightly worse right ventricular ejection fraction and underwent more catheter interventions.

    Read Publication

  • Factors associated with neurodevelopment for children with single ventricle lesions

    C. Goldberg, J Pediatr 2014; 165(3): 490-496.

    This study measured neurodevelopment at 3 years of age and compared it to neurodevelopment at 14 months of age in children enrolled in the Single Ventricle Reconstruction trial. Scores on tests to evaluate neurodevelopment were lower at 3 years of age when compared to a normal population. The results suggest that even when 14-month scores are within the normal range, children with single ventricle heart defects may be at risk for developmental impairment at pre-school age and beyond. Therefore, all children with HLHS and related single ventricle malformations should be followed longitudinally to improve recognition of delays and potential for intervention.

    Read Publication

  • Longitudinal assessment of growth in hypoplastic left heart syndrome: results from the single ventricle reconstruction trial

    P. Burch, J Am Heart Assoc 2014; 3(3):e000079.

    Poor growth is associated with poor prognosis in several disease processes. While children with single ventricle heart disease are known to be smaller than their peers at birth, there is limited information regarding growth and development in survivors. In this paper we show that single ventricle survivors continue to grow poorly with regards to both height and weight through the first two surgical palliations and at three years of age.

    Read Publication

  • Impact of Initial Shunt Type on Cardiac Size and Function in Children with Single Right Ventricle Anomalies prior to the Fontan Procedure—The Single Ventricle Reconstruction Extension Trial

    P. Frommelt, J Am Coll Cardiol 2014; 64(19):2026-35.

    The initial shunt type at the Norwood procedure used to supply blood flow to the lungs in infants with single right ventricle anomalies may influence heart muscle function during the second and third years of life. This study tested heart muscle function in children in the SVR trial, comparing those who had a right ventricle-to-pulmonary artery shunt versus the modified Blalock-Taussig shunt. While there were no differences between the groups, a markedly enlarged heart, poor heart muscle function, and significant heart valve enlargement/dysfunction at 14 months of age was associated with poorer survival to the Fontan operation.

    Read Publication

  • Factors affecting Fontan length of stay: Results from the Single Ventricle Reconstruction trial

    C. Ravishankar, J Thorac Cardiovasc Surg. 2016; 151(3):669-675.

    In the Single Ventricle Reconstruction trial, infants with hypoplastic left heart syndrome (HLHS) who received a right-ventricle-to-pulmonary-artery shunt (RVPAS) versus a modified Blalock-Taussig shunt (MBTS) had lower early postoperative mortality, but more complications at 14 months. This study explored the effect of shunt type and other patient, medical, and surgical factors on postoperative length of stay (LOS) after the Fontan operation. The type of shunt received at the Norwood surgery did not affect how long a baby stayed in the hospital for the Fontan surgery. Rather, more medical complications before the operation resulted in longer LOS after the Fontan operation.

    Read Publication

  • Variation in care for children undergoing the Fontan operation for hypoplastic left heart syndrome

    A. W. Eckhauser, Cardiol Young. 2019 Dec;29(12):1510-1516.

    Read Publication

  • Norwood Shunt Type is Not Predictive of Arrhythmias at 6-years: Analysis from the Single Ventricle Reconstruction Trial

    N. Cain, Journal of the American College of Cardiology 2022; 169:107-112.

    This study compared the effect of both shunt type and Fontan type on the incidence of abnormal heart rhythms (arrhythmias) by 6 years of age in the Pediatric Heart Network Single Ventricle Reconstruction Extension Study (SVRII). By 6 years of age, benign ventricular beats were common in the SVR II population, and it was common for participants to be on medication to treat abnormal heart rhythms, but most of those medications also support heart function. Of the 7 patients with death or transplant between 2-6 years, none had ventricular arrhythmias, but compared with transplant-free survivors, they had some differences in ECG measurements (a longer QRS and a trend toward a longer QTc interval). Fast arrhythmias that begin in the top chambers of the heart (atrial tachyarrhythmias) varied by Fontan type, but not by shunt type. We concluded that, despite the potential for increased risk of ventricular arrhythmias and sudden death in the RV to PA shunt group, the data from the SVR and SVRII studies do not show any significant differences by shunt type or increased risk by 6 years of follow-up. The findings support the need for ongoing surveillance for arrhythmias in the SVR population.

    Read Publication

  • The Relationship of Family Factors to Psychosocial Outcomes in Children with Hypoplastic Left Heart Syndrome at 6 Years of Age

    K. A. Mussatto, The Journal of Pediatrics 2023; 255:50-57.

    Hypoplastic left heart syndrome (HLHS) has a significant impact on both children and families. The purpose of this study was to gain an understanding of how family factors (parent mental health, quality of life, family resources, function and family management of condition) are associated with psychosocial outcomes in children with HLHS at 6 years of age. Parent mental health, quality of life, family resources and family function had no significant relationships to child psychosocial outcomes. Parent perceptions that their child had a normal life despite their heart condition, that the condition was manageable and had a lower impact on family daily life were associated with better child adaptive behavior, adaptive skills and fewer internalizing behavior problems (depression, anxiety, somatic complaints). Improved understanding of the associations between family factors and child outcomes should guide counseling and the development of tailored interventions to capitalize on each family’s strengths.

    Read Publication

description

Single Ventricle Reconstruction Follow-Up 3 (SVR III)

(Observational Study)

This is a second follow-up of the Single Ventricle Reconstruction (SVR) trial which aimed to see which shunt type was best for infants with single ventricle heart defects undergoing the Norwood operation. The purpose of this study is to see which type of shunt is most effective by later school age.

  • Assessment of Growth Six Years after the Norwood Procedure: Results from the Single Ventricle Reconstruction Trial

    P. Burch, J. Pediatr. 2017; 180:270-274.e6.

    There is limited information regarding the long-term growth and development in survivors with single ventricle heart disease. This paper assesses growth in these patients after their final palliative surgery until they are school age. These children continue to grow poorly with regards to both height and weight with height being affected to a greater extent than weight.

    Read Publication

  • Heart failure after the Norwood procedure: An analysis of the Single Ventricle Reconstruction Trial

    W.T. Mahle, J Heart Lung Transplant. 2018 Jul;37(7):879-885.

    Heart failure is a known complication following the Norwood procedure for single ventricle anomalies. Examination of the Single Ventricle Reconstruction (SVR) trial cohort revealed that almost 15% of participants developed heart failure following discharge from the Norwood procedure. Shunt type had no association with heart failure. The risk for developing heart failure was highest in the first year of life. Over half of the children who developed heart failure were listed for transplant, though a significant number died while awaiting a transplant. Among transplant-free survivors to 6 years of age, fewer than 5% of children with palliated single ventricle congenital heart disease had class IV symptomatic heart failure. Several procedure and patient-related factors were associated with development of heart failure, including impaired right ventricular function after the Norwood procedure.

    Read Publication

  • Utilisation of early intervention services in young children with hypoplastic left heart syndrome

    K. Mussatto, Cardiol Young. 2018; 28(1):126-133.

    Children with hypoplastic left heart syndrome are at a risk for neurodevelopmental delays. This study looked at the types of early intervention services (e.g. speech, occupational, physical therapy) and how frequently services were used from age 1 to 4 years in children who participated in the SVR trial. Significant delay was reported by parents in 18-43% of children at ages 3 and 4. More than half of the children (52-69%) were not receiving services at any age and 20-32% were receiving two or more therapies each year. Despite significant neurodevelopmental delays, early intervention service utilization was low in this group of children.

    Read Publication

  • Transplant-Free Survival and Interventions at 6 Years in the Single Ventricle Reconstruction Trial

    J.W. Newburger, Circulation. 2018 May; 137(21):2246-2253.

    We examined transplant-free survival and other outcomes at 6 years after the Norwood procedure with a right ventricle-to-pulmonary artery shunt (RVPAS) compared to a modified Blalock‒Taussig shunt (MBTS) in children enrolled in the PHN’s Single Ventricle Reconstruction (SVR) trial. The RVPAS group had similar survival without needing a heart transplant at 6 years but required more catheter interventions before the Fontan procedure. After the Fontan procedure, the two shunt groups had similar rates of transplant-free survival and of catheter interventions, as well as similar right heart function, cardiac symptoms, and complications. However, children in both groups had a steady increase in complications over time; by 6 years, 20% had suffered a blood clot, 15% a seizure, and 7.5% a stroke. These data emphasize the importance of close follow-up and the need to find new strategies to improve the long-term outlook for children with single ventricle anomalies.

    Read Publication

  • Impact of Initial Shunt Type on Echocardiographic Indices in Children After Single Right Ventricle Palliations—the SVR Trial at 6 Years

    P. C. Frommelt, Circ Cardiovasc Imaging. 2019 Feb; 12(2): e007865.

    Read Publication

  • Gestational Age, Birth Weight, and Outcomes Six Years After the Norwood Procedure

    T. A. Miller, Pediatrics. 2019 May; 143(5): e20182577.

    Read Publication

  • Behavior and Quality of Life at 6 Years for Children With Hypoplastic Left Heart Syndrome

    C. S. Goldberg, Pediatrics. 2019 Nov; 144(5): e20191010.

    Read Publication

  • The Pediatric Heart Network’s study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): Design and Adaptations

    C. S. Goldberg, MD. American Heart Journal. 2022 Dec; 254:216-227.

    The purpose of this paper is to describe the approach to the long-term follow-up of the Single Ventricle Reconstruction (SVR) cohort through the study familiarly known as SVR III. The original SVR trial aimed to understand what type of surgical connection to the pulmonary arteries worked better for infants with hypoplastic left heart syndrome. The individuals enrolled in the SVR trial were then recruited for long-term follow-up, asked to return at 10-12.5 years for an in person evaluation which included cardiac MRI, echocardiogram, exercise testing and neurodevelopmental assessments. Also, every year, through age 16 years, medical history information was collected. Details of each assessment and the medical history form are included in this manuscript. 74% of the eligible cohort, participated in SVR III. Approaches to engaging patients and families in the study and needed adaptations due to participant age and the COVID pandemic are shared.

    Read Publication

description

TEAM 4 Growth RCT

(Passive Range of Motion vs. Standard of Care)

The purpose of TEAM 4 Growth RCT is to learn whether passive range-of-motion exercises can help babies with Hypoplastic Left Heart Syndrome or other single right ventricle anomalies grow better, help their brains develop, and bones be stronger.

  • Design and methods for the training in exercise activities and motion for growth (TEAM 4 growth) trial: A randomized controlled trial

    L. M. Lambert, International Journal of Cardiology. 2022 Jul 15;359:28-34.

    Read Publication

description

Udenafil

(Dosing Study)

This is the first Udenafil study in children or teens that have had Fontan surgery. This study aimed to learn about the possible benefit of Udenafil for children who have had a Fontan operation and to determine which dose of Udenafil is best.

  • Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation

    D. Goldberg, Am Heart J. 2017; 188:42-52.

    The purpose of this study was to identify a safe dose of udenafil in teens with single ventricle heart disease. The participants were assigned to placebo or once-a-day or twice-a-day dosing, at different strengths. The 87.5 mg twice-a-day dosing regimen was well tolerated and showed the most consistent drug levels in the blood. This dose was used for the phase III FUEL (Fontan Udenafil Exercise Longitudinal) clinical trial.

    Read Publication

description

Ventricular Volume Variability

(Observational Study)

This study was done to help us understand why there might be errors in measurements and the true change in heart function values over time.

  • The Ventricular Volume Variability Study of the Pediatric Heart Network: Study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy

    S. Colan, J Am Soc Echocardiogr 2012; 25:842-54.

    Read Publication

  • Variability of M-mode versus two-dimensional echocardiography measurements in children with dilated cardiomyopathy

    C. Lee, Pediatr Cardiol 2014; 35(4):658-67.

    Read Publication

  • Predictors of disease progression in pediatric dilated cardiomyopathy

    K. Molina, Circ Heart Fail 2013; 6(6): 1214–1222.

    Read Publication

  • The reproducibility and absolute values of echocardiographic measurements of left ventricular size and function in children are algorithm dependent

    R. Margossian, J Am Soc Echocardiogr 2015; 28(5):549-558.

    Read Publication

  • Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy

    S. Reddy, Pediatr Res. 2015 Feb; 77(2): 363–369.

    Read Publication

  • Systolic-diastolic functional coupling in healthy children and in those with dilated cardiomyopathy

    M. K. Friedberg, J Appl Physiol 2016; 120(11):1301-1318.

    Read Publication

  • Reproducibility of Left Ventricular Dimension Versus Area Versus Volume Measurements in Pediatric Patients With Dilated Cardiomyopathy

    E.S. Selamet Tierney, Circ Cardiovasc Imaging 2017; 10(11). pii: e006007.

    There are multiple echocardiographic methods in common clinical use for measuring left ventricular size and function. Clinical management is often based on both individual evaluations and longitudinal trends, but it is generally not possible or practical to have the same personnel perform and interpret the echocardiographic assessment over time. Using data from the PHN’s, Ventricular Volume Study in children with dilated cardiomyopathy, we investigated the impact of observer and sonographer variation on reproducibility of dimension, area, and volume methods to determine the most reproducible method for both individual and sequential evaluations. Compared to dimension and area methods, left ventricular measurements by volume method have the best reproducibility in settings where assessment is not performed by the same personnel. In an era in which left ventricular function is not assessed routinely by volume methods (i.e., ejection fraction) in many pediatric echocardiographic laboratories, this study provides important information on reproducibility that could impact long-term management of pediatric dilated cardiomyopathy.

    Read Publication

  • Left Ventricular Dysfunction is Associated with Intraventricular Dyssynchrony by 3-Dimensional Echocardiography in Children

    G. Baker, J Am Soc Enchocardiogr 2008; 21(3):230-233.

    “Dyssynchrony” means that parts of the heart do not squeeze at the same time. This causes less efficient ejection of blood and contributes to heart failure. There is little data on dyssynchrony in children. This small study looked at whether 3-dimensional echocardiography (heart ultrasound) can be used to identify dyssynchrony in healthy children and children with poor heart function. The results show that 3D echocardiography can be used to look at dyssynchrony in children, and that patients with poorer heart function have more dyssynchrony.

    Read Publication